These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 31734189)
1. Different patterns of hepatocellular carcinoma-related malign thrombosis in Ayan A; Can F; Goker Ü; Alkan S; Çınar A; Arslan N Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(3):169-172. PubMed ID: 31734189 [TBL] [Abstract][Full Text] [Related]
2. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma. Lee M; Jeon JY; Neugent ML; Kim JW; Yun M Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188 [TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma. Sun L; Wu H; Pan WM; Guan YS World J Gastroenterol; 2007 Sep; 13(33):4529-32. PubMed ID: 17724816 [TBL] [Abstract][Full Text] [Related]
4. Value of Wu B; Zhang Y; Tan H; Shi H Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961 [TBL] [Abstract][Full Text] [Related]
5. Incidentally found parotid gland lesion in Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma. Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070 [TBL] [Abstract][Full Text] [Related]
8. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911 [TBL] [Abstract][Full Text] [Related]
9. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation. Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226 [TBL] [Abstract][Full Text] [Related]
10. Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection. Morio K; Kawaoka T; Aikata H; Namba M; Uchikawa S; Kodama K; Ohya K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Nakamura Y; Akagi M; Awai K; Kobayashi T; Ohdan H; Chayama K Eur J Radiol; 2020 Mar; 124():108828. PubMed ID: 31955034 [TBL] [Abstract][Full Text] [Related]
11. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. Sun L; Guan YS; Pan WM; Chen GB; Luo ZM; Wei JH; Wu H World J Gastroenterol; 2008 Feb; 14(8):1212-7. PubMed ID: 18300346 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma. Castilla-Lièvre MA; Franco D; Gervais P; Kuhnast B; Agostini H; Marthey L; Désarnaud S; Helal BO Eur J Nucl Med Mol Imaging; 2016 May; 43(5):852-859. PubMed ID: 26577938 [TBL] [Abstract][Full Text] [Related]
13. Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT. Agarwal KK; Shah D; Shah N; Mayank M Clin Nucl Med; 2017 Nov; 42(11):e472-e474. PubMed ID: 28922192 [TBL] [Abstract][Full Text] [Related]
15. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736 [TBL] [Abstract][Full Text] [Related]
16. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma. Lee M; Ko H; Yun M Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847 [TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of microvascular invasion of hepatocellular carcinoma using Hyun SH; Eo JS; Song BI; Lee JW; Na SJ; Hong IK; Oh JK; Chung YA; Kim TS; Yun M Eur J Nucl Med Mol Imaging; 2018 May; 45(5):720-726. PubMed ID: 29167923 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT. Chotipanich C; Kunawudhi A; Promteangtrong C; Tungsuppawattanakit P; Sricharunrat T; Wongsa P Asian Pac J Cancer Prev; 2016; 17(7):3569-73. PubMed ID: 27510010 [TBL] [Abstract][Full Text] [Related]
19. Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma. Kobayashi T; Aikata H; Honda F; Nakano N; Nakamura Y; Hatooka M; Morio K; Morio R; Fukuhara T; Masaki K; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Ohdan H; Awai K; Chayama K J Comput Assist Tomogr; 2016; 40(4):524-30. PubMed ID: 26966955 [TBL] [Abstract][Full Text] [Related]
20. Does dual-time-point Wu B; Zhao Y; Zhang Y; Tan H; Shi H Hell J Nucl Med; 2017; 20(1):79-82. PubMed ID: 28315913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]